Research Article| Volume 250, P92-97, January 01, 2018

Download started.


Percutaneous coronary intervention of bifurcation lesions and platelet reactivity

Published:October 06, 2017DOI:



      Although bifurcation percutaneous coronary intervention (PCI) is associated with lower procedural success rates and higher risk of complications, there are little data regarding outcomes after successful bifurcation PCI with contemporary stents and techniques. Whether residual platelet reactivity (PR) affects outcomes differently after bifurcation versus non-bifurcation PCI is also unknown. We studied the association between bifurcation PCI, PR, and clinical outcomes among patients undergoing successful PCI with drug-eluting stents.


      Patients in the prospective, multicenter ADAPT-DES study were stratified according to whether they underwent bifurcation PCI. Two-year outcomes were compared between groups using Cox proportional hazards models. Target vessel failure (TVF) was defined as the composite of all-cause death, myocardial infarction, and ischemia-driven target vessel revascularization.


      Among the 8582 patients included in ADAPT-DES, 1276 (15%) had bifurcation PCI. Bifurcation PCI was independently associated with increased risk of TVF (adjusted hazard ratio [HR] 1.26, 95% confidence interval [CI] 1.08–1.46, p = 0.003), driven by higher risk of myocardial infarction (5.9% vs. 4.6%, p = 0.033) and ischemia-driven target vessel revascularization (13.0% vs. 9.2%, p < 0.0001). There was no statistical interaction between PR and bifurcation PCI regarding TVF risk (adjusted pinteraction = 0.87). Stenting of both bifurcation branches was associated with the highest risk of TVF (adjusted HR 1.91, 95% CI 1.48–2.46 versus non-bifurcation PCI; ptrend < 0.001).


      Bifurcation PCI is associated with a higher risk of 2-year adverse ischemic events than non-bifurcation PCI, a risk that is particularly high when both bifurcation branches are stented, and with HPR conferring similar risk for bifurcation and non-bifurcation PCI.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gao X.F.
        • Zhang Y.J.
        • Tian N.L.
        • et al.
        Stenting strategy for coronary artery bifurcation with drug-eluting stents: a meta-analysis of nine randomised trials and systematic review.
        EuroIntervention. 2014; 10: 561-569
        • Colombo A.
        • Moses J.W.
        • Morice M.C.
        • et al.
        Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
        Circulation. 2004; 109: 1244-1249
        • Pan M.
        • de Lezo J.S.
        • Medina A.
        • et al.
        Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.
        Am. Heart J. 2004; 148: 857-864
        • Steigen T.K.
        • Maeng M.
        • Wiseth R.
        • et al.
        Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study.
        Circulation. 2006; 114: 1955-1961
        • Ferenc M.
        • Gick M.
        • Kienzle R.P.
        • et al.
        Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions.
        Eur. Heart J. 2008; 29: 2859-2867
        • Colombo A.
        • Bramucci E.
        • Sacca S.
        • et al.
        Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (coronary bifurcations: application of the crushing technique using sirolimus-eluting stents) study.
        Circulation. 2009; 119: 71-78
        • Hildick-Smith D.
        • de Belder A.J.
        • Cooter N.
        • et al.
        Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British bifurcation coronary study: old, new, and evolving strategies.
        Circulation. 2010; 121: 1235-1243
        • Chen S.L.
        • Santoso T.
        • Zhang J.J.
        • et al.
        A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial.
        J. Am. Coll. Cardiol. 2011; 57: 914-920
        • Song Y.B.
        • Hahn J.Y.
        • Song P.S.
        • et al.
        Randomized comparison of conservative versus aggressive strategy for provisional side branch intervention in coronary bifurcation lesions: results from the SMART-STRATEGY (smart angioplasty research team-optimal strategy for side branch intervention in coronary bifurcation lesions) randomized trial.
        J. Am. Coll. Cardiol. Intv. 2012; 5: 1133-1140
        • Maeng M.
        • Holm N.R.
        • Erglis A.
        • et al.
        Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic bifurcation study 5-year follow-up results.
        J. Am. Coll. Cardiol. 2013; 62: 30-34
        • Lassen J.F.
        • Holm N.R.
        • Banning A.
        • et al.
        Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European bifurcation club.
        EuroIntervention. 2016; 12: 38-46
        • Dzavik V.
        • Kharbanda R.
        • Ivanov J.
        • et al.
        Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle.
        Am. Heart J. 2006; 152: 762-769
        • Miyazaki Y.
        • Nomura S.
        • Miyake T.
        • et al.
        High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles.
        Blood. 1996; 88: 3456-3464
        • Stone G.W.
        • Witzenbichler B.
        • Weisz G.
        • et al.
        Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
        Lancet. 2013; 382: 614-623
        • Stone G.W.
        • McLaurin B.T.
        • Cox D.A.
        • et al.
        Bivalirudin for patients with acute coronary syndromes.
        N. Engl. J. Med. 2006; 355: 2203-2216
        • Cutlip D.E.
        • Windecker S.
        • Mehran R.
        • et al.
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Al Suwaidi J.
        • Berger P.B.
        • Rihal C.S.
        • et al.
        Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions.
        J. Am. Coll. Cardiol. 2000; 35: 929-936
        • Hahn J.Y.
        • Chun W.J.
        • Kim J.H.
        • et al.
        Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II registry (COronary BIfurcation Stenting).
        J. Am. Coll. Cardiol. 2013; 62: 1654-1659
        • Genereux P.
        • Kini A.
        • Lesiak M.
        • et al.
        Outcomes of a dedicated stent in coronary bifurcations with large side branches: a subanalysis of the randomized TRYTON bifurcation study.
        Catheter. Cardiovasc. Interv. 2016; 87: 1231-1241
        • Genereux P.
        • Kumsars I.
        • Schneider J.E.
        • et al.
        Dedicated bifurcation stent for the treatment of bifurcation lesions involving large side branches: outcomes from the Tryton confirmatory study.
        J. Am. Coll. Cardiol. Intv. 2016; 9: 1338-1346
        • Genereux P.
        • Kumsars I.
        • Lesiak M.
        • et al.
        A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
        J. Am. Coll. Cardiol. 2015; 65: 533-543
        • Brar S.S.
        • Gray W.A.
        • Dangas G.D.
        • Leon M.B.
        • Aharonian V.
        Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials.
        EuroIntervention. 2009; 5: 475-484
        • Moussa I.D.
        • Klein L.W.
        • Shah B.
        • et al.
        Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).
        J. Am. Coll. Cardiol. 2013; 62: 1563-1570
        • Akkerhuis K.M.
        • Alexander J.H.
        • Tardiff B.E.
        • et al.
        Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?.
        Circulation. 2002; 105: 554-556
        • Abdelmeguid A.E.
        • Whitlow P.L.
        • Sapp S.K.
        • Ellis S.G.
        • Topol E.J.
        Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure.
        Circulation. 1995; 91: 2733-2741
        • Popma J.J.
        • Satler L.F.
        • Pichard A.D.
        • et al.
        Vascular complications after balloon and new device angioplasty.
        Circulation. 1993; 88: 1569-1578
        • Genereux P.
        • Madhavan M.V.
        • Mintz G.S.
        • et al.
        Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy and harmonizing outcomes with revascularization and stents in acute myocardial infarction trials).
        Am. J. Cardiol. 2014; 113: 930-935
        • Madhavan M.V.
        • Genereux P.
        • Palmerini T.
        • et al.
        The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial.
        J. Invasive Cardiol. 2015; 27: 203-211
        • Grundeken M.J.
        • Asgedom S.
        • Damman P.
        • et al.
        Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies.
        EuroIntervention. 2013; 9: 195-203
        • Buysschaert I.
        • Dubois C.L.
        • Dens J.
        • et al.
        Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study.
        EuroIntervention. 2013; 9: 573-581
        • Legutko J.
        • Yamawaki M.
        • Costa R.A.
        • Costa M.A.
        IVUS in bifurcation stenting: what have we learned?.
        EuroIntervention. 2015; 11: V55-8
        • Stone G.W.
        • Sabik J.F.
        • Serruys P.W.
        • et al.
        Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
        N. Engl. J. Med. 2016; 375: 2223-2235
        • Makikallio T.
        • Holm N.R.
        • Lindsay M.
        • et al.
        Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
        Lancet. 2016; 388: 2743-2752